Lazertinib in Pretreated Epidermal Growth Factor Receptor T790M-Mutated Advanced Non-small Cell Lung Cancer: A Real-World Multicenter Study

被引：0
|
作者：
Ahn, B-C. [1 ,2 ]
Kim, H. [2 ]
Lee, J. [2 ]
Lee, J. B. [2 ]
Hong, M. -H. [2 ]
Kim, H. R. [2 ]
Cho, B. C. [2 ]
Lim, S. M. [2 ]
机构：
[1] Natl Canc Ctr, Goyang Si, South Korea
[2] Yonsei Univ, Severance Hosp, Yonsei Canc Ctr, Coll Med, Seoul, South Korea
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
Lazertinib; real-world data; T790M EGFR mutation;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP12.01-47
引用
收藏
页码：S659 / S660
页数：2
相关论文
共 50 条
  • [41] Epidermal growth factor receptor in non-small cell lung cancer
    Prabhakar, Charles N.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2015, 4 (02) : 110 - 118
  • [42] FIRST LINE GEFITINIB IN YOUNGER PATIENTS WITH EPIDERMAL GROWTH FACTOR RECEPTOR MUTATED ADVANCED NON-SMALL CELL LUNG CANCER
    Elhidsi, Mia
    Hudoyo, Ahmad
    Andarini, Sita
    RESPIROLOGY, 2015, 20 : 100 - 100
  • [43] Real-world analysis of the EGFR T790M mutation in plasma and tissue biopsy from advanced non-small cell lung cancer
    Lee, Eun Hye
    Kwak, Se Hyun
    Kim, Chi Young
    Lee, Sang Hoon
    Kim, Eun Young
    Chang, Yoon Soo
    RESPIROLOGY, 2023, 28 : 99 - 100
  • [44] Inherited Germline T790M Mutation and Somatic Epidermal Growth Factor Receptor Mutations in Non-small Cell Lung Cancer Patients
    Tibaldi, Carmelo
    Giovannetti, Elisa
    Vasile, Enrico
    Boldrini, Laura
    Gallegos-Ruiz, Marielle I.
    Bernardini, Ilaria
    Incensati, Roberto
    Danesi, Romano
    Cappuzzo, Federico
    Peters, Godefridus J.
    Fontanini, Gabriella
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (02) : 395 - 396
  • [45] Real-World Treatment Patterns, Epidermal Growth Factor Receptor (EGFR) Testing and Outcomes in EGFR-Mutated Advanced Non-small Cell Lung Cancer Patients in Belgium: Results from the REVEAL Study
    Kristof Cuppens
    Liesbet Lodewyckx
    Ingel Demedts
    Lore Decoster
    Benoît Colinet
    Koen Deschepper
    Annelies Janssens
    Daniella Galdermans
    Thierry Pieters
    Drugs - Real World Outcomes, 2021, 8 : 141 - 152
  • [46] Real-World Treatment Patterns, Epidermal Growth Factor Receptor (EGFR) Testing and Outcomes in EGFR-Mutated Advanced Non-small Cell Lung Cancer Patients in Belgium: Results from the REVEAL Study
    Cuppens, Kristof
    Lodewyckx, Liesbet
    Demedts, Ingel
    Decoster, Lore
    Colinet, Benoit
    Deschepper, Koen
    Janssens, Annelies
    Galdermans, Daniella
    Pieters, Thierry
    DRUGS-REAL WORLD OUTCOMES, 2021, 8 (02) : 141 - 152
  • [47] Real-World Global Data on Targeting Epidermal Growth Factor Receptor in Stage III Non-Small Cell Lung Cancer: The Results of the KINDLE Study
    Jazieh, A.
    Onal, H.
    Tan, D.
    Soo, R.
    Prabhash, K.
    Kumar, A.
    Huggenberger, R.
    Robb, S.
    Cho, B. C.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S110 - S111
  • [48] Efficacy and safety of ASK120067 (limertinib) in patients with locally advanced or metastatic EGFR T790M-mutated non-small cell lung cancer: A multicenter, singlearm, phase IIb study.
    Li, Baolan
    Wu, Lin
    Pan, Yueyin
    Pan, Zhijie
    Liu, Yunpeng
    Fan, Yun
    Ji, Yinghua
    Fang, Jian
    Shi, Qin
    Li, Kai
    Shi, Jianhua
    Gao, Hongjun
    Hu, Yanping
    Wang, Xiang
    He, Zhiyong
    Ma, Rui
    Zhang, Yu
    Chen, Hongyu
    Song, Tingting
    Shi, Yuankai
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [49] A Real-World Study in Advanced Non-Small Cell Lung Cancer with KRAS Mutations
    Lei, Lei
    Wang, Wen-xian
    Yu, Zong-yang
    Liang, Xian-bin
    Pan, Wei-wei
    Chen, Hua-fei
    Wang, Li-ping
    Fang, Yong
    Wang, Min
    Xu, Chun-wei
    Fang, Mei-yu
    TRANSLATIONAL ONCOLOGY, 2020, 13 (02): : 329 - 335
  • [50] ASTRIS: A multicenter, real world treatment study of osimertinib in EGFR T790M positive non-small cell lung cancer (NSCLC)
    Cheema, P. K.
    Chen, Y-M.
    de Marinis, F.
    Freitas, H. C.
    Kim, S-W.
    Milner, A.
    Provencio, M.
    Rigas, J.
    Wu, Y-L.
    ANNALS OF ONCOLOGY, 2017, 28
12345